Humana Inc. (NYSE:HUM) finished Friday with a subtraction of -$1.12 to close at $493.91, a downside of -0.23 percent. An average of 980,120 shares of common stock have been traded in the last five days. There was a gain of $9.63 in the past week, and it reached a new high 13 times over the past 12 months. The last 20 days have seen an average of 1,612,555 shares traded, while the 50-day average volume stands at 1,657,976.
HUM stock has increased by 16.41% in the last month. The company shares reached their 1-month lowest point of $423.29 on 07/13/23. With the stock rallying to its 52-week high on 05/09/23, shares of the company touched a low of $423.29 and a high of $571.30 in 52 weeks. It has reached a new high 8 times so far this year and lost -3.57% or -$18.28 in price. In spite of this, the price is down -13.55% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
HUM stock investors should be aware that Humana Inc. (HUM) stock had its last reported insider trading activity 100 days ago on May 04. In this transaction, the insider spent $2,187,226. President & CEO, BROUSSARD BRUCE D, disposed of 17,575 shares at a price of $505.85 on Feb 27. The insider now owns more than $8,890,233 worth of shares. Prior to that, Chief Administrative Officer Huval Timothy S. went on to Sale 2,628 shares at $510.30 each on Feb 27. An amount of $1,341,080 was transacted.
Valuation Metrics
Humana Inc. (HUM) has a trailing price-to-earnings (P/E) ratio of 18.43. The stock’s beta is 0.65. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.63, the price-to-book (PB) ratio at 3.72, and the price-to-cash flow ratio at 20.19.
The company has a payout ratio of 14.20%. The company’s most recent quarterly dividend payment was $0.8850 a share, without any change from last year. Its latest increase dividend $0.0975 reported on Thursday February 16 2023.
Financial Health
Further, the company has a long term debt to equity ratio of 0.59 and a total debt to equity ratio of 0.72 for the recent quarter. Its gross profit as reported stood at $17.18 billion compared to revenue of $92.87 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Humana Inc.’s return on assets was 5.70%.
Earnings Surprise
For the recent quarter, Humana Inc. had $9.72 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $959.0 million in the quarter, while revenues of $1.24 billion were grew 27.42%. Shareholders own equity worth $123.91 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Humana Inc. (HUM) price momentum. RSI 9-day as of the close on 11 August was 76.91%, suggesting the stock is Overbought, with historical volatility in this time frame at 27.38%.
As of today, HUM’s price is $494.04 +1.99% or $9.63 from its 5-day moving average. HUM is currently trading +13.56% higher than its 20-day SMA and -0.10% lower than its 100-day SMA. However, the stock’s current price level is -1.59% below the SMA50 and -5.37% below the SMA200.
The stochastic %K and %D were 89.58% and 90.56%, respectively, and the average true range (ATR) was 9.30. With the 14-day stochastic at 88.20% and the average true range at 9.67, the RSI (14) stands at 69.55%. The stock has reached 7.05 on the 9-day MACD Oscillator while the 14-day reading was at 19.31.
Analyst Ratings
JP Morgan downgraded Humana Inc. (NYSE: HUM) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as an Overweight. The consensus rating for Humana Inc. (HUM) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell HUM, while 6 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 16 others rate it as a “buy”.
What is HUM’s price target for the next 12 months?
Analysts predict a range of price targets between $468.00 and $640.00, with a median target of $585.00. Taking a look at these predictions, the average price target given by analysts for Humana Inc. (HUM) stock is $583.95.
